Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PRCH | TBBK |
|---|---|---|
| Price | $17.35 | $48.33 |
| Change today | ▲ 0.23% | ▼ 0.98% |
| Market cap | $1.97B | $1.97B |
| Return, 3 months | +18.2% | -26.3% |
| Return, year to date | +90.0% | -28.4% |
| Return, 1 year | +5.5% | -38.4% |
| P/E (TTM) | -133.5 | 9.1 |
| P/B | -166.8 | 2.8 |
| P/E percentile vs own 5y | – | 3rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +11.7% | +31.6% |
| Net profit growth (YoY) | -271.6% | +4.9% |
| Gross margin | 62.2% | – |
| Operating margin | -2.9% | – |
| Net margin | -10.0% | 34.5% |
| Return on equity | – | 29.6% |
| Analyst target vs. price | +13.5% | +66.9% |
| Analyst buy share | 83% | 100% |
| RSI (14) | 60 | 27 |
| 30-day volatility | 35.3% | 75.8% |
| Max drawdown, 1 year | -65.0% | -40.1% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
